Chinese patent medicine for treatment of vocal cord leukoplakia

Abstract

The invention discloses a Chinese patent medicine for treatment of vocal cord leukoplakia in the technical field of Chinese patent medicines. The Chinese patent medicine for treatment of vocal cord leukoplakia comprises the following components: 110-210 g of raw radix paeoniae alba; 110 g to 210 g of radix glehniae; 110 g to 210 g of radix scrophulariae; the Chinese patent medicine for treatment of vocal cord leukoplakia is prepared into pills by adopting roots, stems, leaf flowers, fruits, seeds, fungi, insects and mineral substances of first-class pure natural Chinese herbal medicines, is developed by starting from the morbidity source of vocal cord leukoplakia in traditional Chinese medicine and aiming at conversion of a syndrome differentiation treatment principle, and the vitality ofvocal cord cells is enhanced, repair of vocal cord mucosa is promoted, deposition of keratinized substances is removed, and diseased tissue recovers vitality. The medicine is mainly used for nourishing yin, removing stasis, tonifying yin, removing necrotic tissue, promoting blood circulation to remove blood stasis, clearing away lung-heat, ventilating qi, strengthening spleen, benefiting lung, reducing phlegm and resolving masses, comprehensively regulates visceral organs related to the pathogenesis, regulates the human body in all directions, reverses the pathology mechanism of the visceral organs and prevents complications. Therefore, basic treatment, overall recovery and standard rate treatment are achieved.

Description

technical field [0001] The invention discloses a Chinese patent medicine for treating vocal cord leukoplakia, and specifically belongs to the technical field of Chinese patent medicines. Background technique [0002] Vocal cord leukoplakia is a nonspecific clinical term for white patches that are not easily removed and are not diagnostic of any other disease of the vocal cords. Under the pathological microscope, the squamous epithelium may show different degrees of thickening of the keratinized layer, which may be parakeratosis or hyperkeratosis, and may have simple hyperplasia, metaplasia, and dysplasia. More than half of the specimens with leukoplakia were free of dysplasia. It has malignant potential, but the term leukoplakia is not equivalent to carcinoma or malignancy III. The incidence of vocal cord leukoplakia is 0.01% to 0.24%, the age at diagnosis ranges from 52 to 66 years, and the male to female ratio is 0.7 to 30:1. Vocal cord leukoplakia occurs mostly in the ...

AI Technical Summary

Problems solved by technology

[0006] The object of the present invention is to provide a kind of Chinese patent medicine for treating vocal cord leukoplakia, in order to solve the problem that the Chinese patent medicine proposed in the background technology cannot completely cure vocal cord leukoplakia, and in the process of taking it, the ability of step-by-step blood pressure reduction is poor, resulting in curative effect. Unstable, difficult to treat completely, toxic and side effects, lack of comprehensive adjustment ability, unable to enter the fundamental treatment after complications occur, the overall recovery cycle becomes longer, and it is difficult to achieve the effect of both standard rate and treatment